Some studies in melanoma have generated TME transcriptome profiles from responders and non-responders receiving ICB45,46, and computational analysis of these profiles illustrated that CD70 expression was associated with T-cell dysfunction and inferior ICB outcomes (Supplementary Figs. 5b and 5c). The gene discussed is CD70; the disease is melanoma.